Adzynma (ADAMTS13, recombinant-krhn)
| Full Name | Adzynma (ADAMTS13, recombinant-krhn) |
| Drug | Adzynma |
| Manufacturer | Takeda Pharmaceuticals U.S.A., Inc. |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | Prophylactic or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP) |
| Disease | Congenital thrombotic thrombocytopenic purpura (c-TTP) |
| Therapeutic Area | Hematology |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-720-0789 |
| Fax Number | 877-251-0709 |
| Product Website | adzynma.com |